•  
• Tweet
•  
•        Print
•  
•         Track Keywords
•  
• 

Komfie Manalo, Opalesque Asia:

Hedge funds slid for their fourth consecutive month in September as shown by the Barclay Hedge Fund Index which is down 1.43% during the month, bringing its year-to-date losses to 1.21%.

"Investor uncertainty fueled by weak growth numbers in the U.S. and China, along with the Fed’s reluctance to raise U.S. interest rates, triggered a global selloff in equities, commodities, and high yield bonds," says Sol Waksman, founder and president of BarclayHedge.

All but one of Barclay’s 18 hedge fund indices lost ground last month. The healthcare & biotechnology index dropped 5.90%, adding to its 4.13% loss in August. The Event Driven Index was down 2.67%, Equity Long Bias lost 2.44%, Distressed Securities gave up 2.05%, and the Emerging Markets Index was down 1.53%.

The Equity Market Neutral Index was the only hedge fund strategy in positive territory for September, with a 0.87% gain.

At the end of three quarters in 2015, the Merger Arbitrage Index is up 4.54%, Equity Market Neutral has gained 4.01%, Pacific Rim Equities have risen 3.92%, Healthcare & Biotechnology is up 3.78%, and European Equities have gained 3.51%.

The Distressed Securities Index has lost 6.66% year-to-date, Emerging Markets are down 4.52%, the Event Driven Index has lost 3.09%, and Equity Long Bias is down 3.02%.

The Barclay Fund of Funds Index lost 1.67% in September, and is down ......................

To view our full article Click here